EUR vs Guinea: Hepatitis B surface antigen (HBsAg) prevalence
EUR
0.1%
in 2024
Guinea
2.8%
in 2024
EUR rank
6th
Guinea rank
7th
Hepatitis B surface antigen (HBsAg) prevalence over time
- EUR
- Guinea
How they compare
Guinea currently reports 2.8% against 0.1% in EUR, a difference of 2.7%.
That makes Guinea's figure about 28.0 times EUR's.
Across all 10 years both countries report, Guinea has been ahead every year.
EUR ranks 6th and Guinea ranks 7th of 7 groups.
Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | EUR | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 2.7% | 2.6% | Guinea |
| 2020s | 0.1% | 2.7% | 2.6% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, EUR or Guinea?
- Guinea, at 2.8% against 0.1% in EUR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between EUR and Guinea?
- 2.7%, with Guinea ahead.
- How many years of comparable data are there for EUR and Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do EUR and Guinea rank globally for hepatitis b surface antigen (hbsag) prevalence?
- EUR ranks 6th and Guinea ranks 7th of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.